STAT Plus: BIO’s new board chair on the industry’s bad reputation: ‘That’s ridiculous’
WASHINGTON — The sprawling trade association for companies making everything from weed killer to CAR-T cancer therapies, the Biotechnology Innovation Organization, has new leadership. But it’s still not apologizing for the toxic reputation many of its member companies have on Capitol Hill, and in the minds of Americans, more generally.
BIO elected Dr. Jeremy Levin, CEO of Ovid Therapeutics, to be its new board chair in June. It was a planned transition, but one that the group insists will foster more open and frequent communication about the positive role biotech companies play in American life. The group also recently hired a new executive vice president to spearhead its messaging.
Continue to STAT Plus to read the full story…
